Drug Profile
Research programme: CNS disorder therapies - BrainCells/Organon
Latest Information Update: 27 Jan 2010
Price :
$50
*
At a glance
- Originator BrainCells; Organon
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued CNS disorders
Most Recent Events
- 23 Oct 2006 Preclinical trials in CNS disorders in USA (unspecified route)